{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:24:08Z","timestamp":1794489848117,"version":"4.9.1"},"reference-count":105,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Med Insights Endocrinol Diabetes"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>Impaired pancreatic \u03b2-cell function is a key feature in the pathophysiology of both type 1 and long-standing type 2 diabetes. C-peptide, produced in 1:1 ratio along with insulin, is secreted at a relatively steady rate over long duration, making it an effective biomarker for endogenous insulin secretion. Given the heterogeneity and complex pathophysiology of diabetes, C-peptide estimation plays an important role in the accurate classification of diabetes and in guiding treatment decisions, particularly for patients needing insulin therapy. In autoimmune diabetes, especially adult-onset forms, C-peptide has gained importance as a biomarker. However, its greatest utility is often observed 3 to 5\u2009years post-diagnosis, when detectable C-peptide levels may help differentiate between MODY (Maturity-onset Diabetes of the Young) and type 2 diabetes. The clinical applications of C-peptide extend beyond diagnosis, including risk stratification for diabetes-related vascular complications, determining pharmacotherapy choices, evaluating hypoglycemia, and even in the context of bariatric surgery. Despite its usefulness, the role of C-peptide in type 2 diabetes remains limited, primarily due to insulin resistance, which may elevate C-peptide levels. Estimating C-peptide is a cost-effective and reliable method, but there is still considerable variation in its application. Factors such as sample collection, timing in relation to meals, and the lack of standardization in assay techniques raise issues regarding the consistency and repeatability of results among various laboratories. This review aims to explore the current evidence surrounding C-peptide estimation in diabetes care, as well as the limitations and uncertainties that continue to challenge its clinical application.<\/jats:p>","DOI":"10.1177\/11795514251397811","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:46:53Z","timestamp":1770983213000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["C-peptide in Precision Diabetes Care and Beyond: A Comprehensive Review"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6956-2915","authenticated-orcid":false,"given":"Eligar Somashekar","family":"Vinay","sequence":"first","affiliation":[{"name":"Imperial College London Diabetes and Endocrine Centre, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bondugulapati","family":"Laxmi Narsimha Rao","sequence":"additional","affiliation":[{"name":"Imperial College London Diabetes and Endocrine Centre, Abu Dhabi, United Arab Emirates"},{"name":"College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naqvi","family":"Saf","sequence":"additional","affiliation":[{"name":"Imperial College London Diabetes and Endocrine Centre, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Das","family":"Gautam","sequence":"additional","affiliation":[{"name":"Imperial College London Diabetes and Endocrine Centre, Al Ain, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12159"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00130.2014"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-017-0265-4"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2013-132068"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0797"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.2337\/dbi23-0012"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijnmhs.2023.009"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)76984-1"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.69.2.505"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/newbio235085a0"},{"key":"e_1_3_3_12_2","first-page":"55","article-title":"Chemical and biological aspects of insulin and proinsulin","volume":"601","author":"Steiner DF","year":"1976","unstructured":"Steiner DF, Terris S, Chan SJ, Rubenstein AH. Chemical and biological aspects of insulin and proinsulin. Acta Med Scand. 1976;601:55-107.","journal-title":"Acta Med Scand"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.157.3789.697"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0970429"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107277"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.24.020173.001521"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112308"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11861111"},{"key":"e_1_3_3_19_2","first-page":"257","article-title":"Hepatic extraction of insulin in humans: comparison of insulin and C-peptide kinetics","volume":"1989","author":"Wajngot A","unstructured":"Wajngot A. Hepatic extraction of insulin in humans: comparison of insulin and C-peptide kinetics. Am J Physiol. 1989;257:E880-E886.","journal-title":"Am J Physiol"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-1379"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12850"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.1.250"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00335.x"},{"key":"e_1_3_3_24_2","first-page":"233","volume":"18","author":"Service J.","year":"1992","unstructured":"Service J. Hypoglycemic disorders. J Diabetes Educ. 1992;18:233-237.","journal-title":"Hypoglycemic disorders. J Diabetes Educ"},{"key":"e_1_3_3_25_2","unstructured":"Burnton LL Chabner BA Knollman BC eds. Goodman and Gillman\u2019s The Pharmacological Basis of Therapeutics."},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.33.5.486"},{"key":"e_1_3_3_27_2","article-title":"Standards of care in diabetes 2025","volume":"48","author":"American Diabetes Association","year":"2025","unstructured":"American Diabetes Association. Standards of care in diabetes 2025. Diabetes Care. 2025;48:S181-S206.","journal-title":"Diabetes Care"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1983.tb08548.x"},{"key":"e_1_3_3_29_2","first-page":"580","article-title":"The impact of C-peptide status on the progression of diabetic nephropathy","volume":"2008","author":"Covic A","unstructured":"Covic A, Schiller A, Constantinescu O, et al. The impact of C-peptide status on the progression of diabetic nephropathy. Eur J Intern Med. 2008;19(8):580-585.","journal-title":"Eur J Intern Med"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.101287"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00275266"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365510050216411"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.125"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2451"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00297450"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1981.tb09793.x"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.11.4.318"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(91)90017-8"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03348682"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.26.1.30"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.129312"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(95)90015-2"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03272.x"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03428.x"},{"issue":"5","key":"e_1_3_3_45_2","first-page":"911","article-title":"Adult-onset autoimmune diabetes in Europe: prevalence, phenotype and association with other autoimmune diseases","volume":"56","author":"Hawa MI","year":"2013","unstructured":"Hawa MI, Kolb H, Schoolt N et al. Adult-onset autoimmune diabetes in Europe: prevalence, phenotype and association with other autoimmune diseases. Diabetologia. 2013;56(5):911-920.","journal-title":"Diabetologia"},{"issue":"3","key":"e_1_3_3_46_2","first-page":"239","article-title":"Latent autoimmune diabetes in adults: current status and new horizons","volume":"2017","author":"Buzzetti R","unstructured":"Buzzetti R, Zampetti S, Maddaloni E. Latent autoimmune diabetes in adults: current status and new horizons. Endocr Rev. 2017;38(3):239-266.","journal-title":"Endocr Rev"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1960-7"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2012.00875.x"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i4.613"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.7266-21"},{"key":"e_1_3_3_51_2","first-page":"2660","article-title":"Impact of obesity on the increasing incidence of type 1 diabetes","volume":"106","author":"Buzzetti R","year":"2021","unstructured":"Buzzetti R, Zampetti S, Pozzilli P. Impact of obesity on the increasing incidence of type 1 diabetes. Diabetes Obes Metab. 2021;106:2660-2669.","journal-title":"Diabetes Obes Metab"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017-00191"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14785"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-1-30"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI134057"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2009.02690.x"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4226-2"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1293"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.99"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05211-7"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-008-0018-x"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa205"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2834"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.2337\/dci21-0043"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-7-199804010-00001"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.3.832"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00404145"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365518509155265"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1984.tb01974.x"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13897"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12222"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1994.tb00253.x"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03348039"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2004.05.001"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.2337\/db20-2208-pub"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2003.00258.x"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2012.07.001"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0258"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12367"},{"key":"e_1_3_3_80_2","first-page":"59981","article-title":"Effect of immunotherapy on C-peptide levels in patients with type I diabetes mellitus: a systematic review of randomized controlled trials","volume":"16","author":"Roy SS","year":"2024","unstructured":"Roy SS, Keshri USP, Alam MS, Wasnik A. Effect of immunotherapy on C-peptide levels in patients with type I diabetes mellitus: a systematic review of randomized controlled trials. Cureus. 2024;16:59981.","journal-title":"Cureus"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2251-0"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0881"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0567"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-010-0249-6"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0085"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/858692"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12541"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1211"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1177\/1479164117710446"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.121950"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1177\/1479164114564900"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2006.09.005"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504273321707"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1410"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-013-2588-9"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70089-X"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1430"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2000.110243"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2007.09.010"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.30.5.377"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200203000-00001"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvad012"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00528"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP14118.OR"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-1022"},{"key":"e_1_3_3_106_2","first-page":"25889","article-title":"Successful resolution of glucose toxicity with the use of fixed-ratio combination injection of basal insulin and short-acting glucagon-like peptide 1 (GLP-1) receptor agonist","volume":"14","author":"Miura H","year":"2022","unstructured":"Miura H, Muramae N, Mori K, Otsui K, Sakaguchi K. Successful resolution of glucose toxicity with the use of fixed-ratio combination injection of basal insulin and short-acting glucagon-like peptide 1 (GLP-1) receptor agonist. Cureus. 2022;14:25889.","journal-title":"Cureus"}],"container-title":["Clinical Medicine Insights: Endocrinology and Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11795514251397811","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11795514251397811","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11795514251397811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:00:25Z","timestamp":1777406425000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11795514251397811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":105,"alternative-id":["10.1177\/11795514251397811"],"URL":"https:\/\/doi.org\/10.1177\/11795514251397811","relation":{},"ISSN":["1179-5514","1179-5514"],"issn-type":[{"value":"1179-5514","type":"print"},{"value":"1179-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"article-number":"11795514251397811"}}